©The Author(s) 2025.
World J Exp Med. Dec 20, 2025; 15(4): 113869
Published online Dec 20, 2025. doi: 10.5493/wjem.v15.i4.113869
Published online Dec 20, 2025. doi: 10.5493/wjem.v15.i4.113869
Table 1 Summary of study participants, clinical manifestations, and diagnostic groupings
| Patient ID | Group | Condition/symptoms |
| P1 | 1: Non-malignant adverse events | Brain fog and chronic fatigue |
| P2 | 1: Non-malignant adverse events | Cardiovascular injury, thrombosis, and chronic fatigue |
| P3 | 1: Non-malignant adverse events | Cardiovascular injury, thrombosis, and chronic fatigue |
| P4 | 2: Cancer | Glioblastoma multiforme |
| P5 | 2: Cancer | Prostate adenocarcinoma |
| P6 | 2: Cancer | Bladder tumor |
| P7 | 2: Cancer | Follicular lymphoma |
| P8 | 2: Cancer | Prostate cancer |
| P9 | 2: Cancer | Glioblastoma multiforme |
| P10 | 2: Cancer | Follicular lymphoma |
- Citation: Von Ranke NL, Zhang W, Anokhin P, Hulscher N, McKernan K, Mccullough P, Catanzaro J. Synthetic messenger RNA vaccines and transcriptomic dysregulation: Evidence from new-onset adverse events and cancers post-vaccination. World J Exp Med 2025; 15(4): 113869
- URL: https://www.wjgnet.com/2220-315x/full/v15/i4/113869.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i4.113869